New hope for Non-Smokers battling advanced lung cancer
Disease control
Recruiting now
This study is testing if adding an investigational drug called LP-300 to standard chemotherapy helps people with advanced lung adenocarcinoma who have never smoked. The goal is to see if this combination can better control the cancer and help patients live longer after their init…
Phase: PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC